CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 104 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04589247
NCT04589247N/ACompleted

Improving Cancer Care by Incorporating the Patient's Voice Into On-treatment Symptom Management

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins·observational·Posted Oct 19, 2020·Updated Sep 25, 2025

In Brief

An observational study for Cancer and 3 related conditions. Completed, enrolled 104 participants across 4 sites.

Detailed Summary

Patient-reported outcome measures (PROMs) is an umbrella term that refers to any report on a health status measure that is reported directly by the patient, without the influence of clinicians or anyone else. PROMs have been shown to more closely reflect a patient's daily health status when compared to physician-reported measures. However, research is needed to evaluate if patient symptom reporting during definitive-intent radiotherapy allows earlier and improved detection of treatment toxicity. The IMPROVE pilot study will describe the proportion of patients with cancer with changes in physician-perception of treatment-related toxicity that result from routine physician review of PROMs reported during definitive radiotherapy.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
CollaboratorsWellSpan Health

Timeline

N/ACompletedFinished
202120222023202420252026
First PostedOct 19, 2020
Enrollment StartNov 16, 2020
Primary CompletionJul 23, 2023
Study CompletionJun 30, 2025
TodayJul 2, 2026
Enrollment to primary: 2.7 yearsPosted 5.7 years ago